← Scroll for more →
Financial Statements — IROHR
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 23.32 | 29.69 | 33.01 | 37.21 | 0.03 | 0.00 | 0.00 | 0.00 | 0.09 | 0.18 | 0.66 |
| Accounts Receivable | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Inventory | 2.21 | 0.85 | 0.96 | 1.85 | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 27.52 | 31.36 | 36.89 | 46.18 | 0.16 | 0.08 | 0.04 | 0.07 | 0.24 | 0.54 | 0.69 |
| Property, Plant & Equipment | 4.52 | 4.57 | 4.61 | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | 0.09 | 0.08 | 0.08 | 0.09 | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Assets* | 7.69 | 7.76 | 7.84 | 10.05 | 73.17 | 73.57 | 72.75 | 71.70 | 70.75 | 69.85 | 69.00 |
| Total Assets | 35.21 | 39.12 | 44.73 | 56.23 | 73.32 | 73.65 | 72.80 | 71.77 | 70.99 | 70.40 | 69.69 |
| Accounts Payable | 1.85 | 0.18 | 0.07 | 2.06 | 0.22 | 0.27 | 0.09 | -- | -- | -- | -- |
| Total Current Liabilities | 11.74 | 19.03 | 24.61 | 38.19 | 72.44 | 3.36 | 2.59 | 1.52 | 1.21 | 1.10 | 0.86 |
| Total Non-current Liabilities* | 0.13 | 0.19 | 0.24 | 0.30 | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 |
| Total Liabilities | 11.86 | 19.22 | 24.85 | 38.49 | 74.95 | 5.88 | 5.11 | 4.04 | 3.73 | 3.62 | 3.38 |
| Retained Earnings | 15.16 | 12.10 | 12.41 | 11.04 | (6.11) | (4.85) | (4.14) | (3.24) | (3.00) | (2.81) | (2.69) |
| Total Stockholder Equity | 23.35 | 19.90 | 19.87 | 17.75 | (6.11) | (4.85) | (4.14) | (3.24) | (3.00) | (2.81) | (2.69) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8.73 | 5.83 | 7.88 | 7.91 | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | 2.49 | 1.46 | 2.02 | 2.34 | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | 6.24 | 4.36 | 5.85 | 5.57 | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | 0.04 | 0.04 | 0.04 | 0.04 | -- | -- | -- | -- | -- | -- | -- |
| Selling, General & Admin | 0.76 | 3.07 | 2.80 | 0.44 | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.13 | 3.63 | 3.33 | 0.98 | -- | -- | -- | -- | -- | -- | -- |
| Operating Income | 5.12 | 0.73 | 8.39 | 4.58 | (0.67) | (0.52) | (0.70) | (0.29) | (0.24) | (0.48) | (0.01) |
| Pretax Income | 4.57 | 0.54 | 7.28 | 4.72 | 0.08 | 0.23 | 0.12 | 0.65 | 0.66 | -- | -- |
| Tax Provision | 1.51 | 0.85 | 2.23 | 1.38 | 0.15 | 0.15 | 0.17 | 0.19 | 0.18 | 0.21 | -- |
| Net Income | 3.06 | (0.31) | 5.05 | 3.34 | (0.06) | 0.08 | (0.05) | 0.47 | 0.48 | 0.47 | (0.01) |
| Basic EPS | 0.06 | (0.01) | -- | 0.07 | -- | -- | -- | -- | -- | -- | -- |
| Diluted EPS | 0.06 | (0.01) | -- | 0.07 | -- | -- | -- | -- | -- | -- | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (7.03) | (3.60) | (3.34) | (3.66) | (1.64) | (0.41) | (0.50) | (0.09) | (0.05) | (0.37) |
| Capital Expenditures | 0.00 | 0.00 | 0.27 | 0.44 | -- | -- | -- | -- | -- | -- |
| Free Cash Flow* | (7.03) | (3.60) | (3.60) | (4.10) | -- | -- | -- | -- | -- | -- |
| Investing Cash Flow | (0.01) | -0.00 | (0.27) | (1.72) | 1.16 | (0.06) | (0.23) | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 0.12 | (1.01) | 0.04 | 0.51 | 0.47 | 0.72 | 0.00 | (0.04) | (0.11) |
← Scroll for more columns →
* Derived from reported values